Gara Jalqabaatti › Baayyee Ulfaataa › Texas › The Woodlands
Qorannoo klinikaalii Baayyee Ulfaataa The Woodlands, TX keessatti
Qorannoo 10 Baayyee Ulfaataa f The Woodlands fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Namoota walitti qabaa jiraSadarkaa 3
- Tcr Institute Llc, Kingwood · Miili 20 fagaatti
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
Namoota walitti qabaa jiraSadarkaa 3
- Activian Clinical Research, Kingwood · Miili 20 fagaatti
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
Namoota walitti qabaa jiraSadarkaa 3
- Martin Diagnostic Clinic, Tomball · Miili 9 fagaatti
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
Namoota walitti qabaa jiraSadarkaa 3
- Activian Clinical Research, Kingwood · Miili 20 fagaatti
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
Namoota walitti qabaa jiraSadarkaa 3
- AURORA-2 Clinical Site, Tomball · Miili 9 fagaatti
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
Namoota walitti qabaa jiraSadarkaa 3
- AURORA-1 Clinical Site, Tomball · Miili 9 fagaatti
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
Namoota walitti qabaa jiraSadarkaa 3
- DM Clinical Research, Tomball · Miili 9 fagaatti
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
Namoota walitti qabaa jiraSadarkaa 3
- Kailera Clinical Site, Tomball · Miili 9 fagaatti
- Kailera Clinical Site, Kingwood · Miili 20 fagaatti
Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes
Namoota walitti qabaa jiraSadarkaa 3
- Kailera Clinical Site, Tomball · Miili 9 fagaatti
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
Namoota walitti qabaa jiraSadarkaa 3
- Northwest Houston Heart Center, Tomball · Miili 9 fagaatti
Qorannoo Baayyee Ulfaataa magaalota biroo keessatti
- San Antonio, TXQorannoo 34
- Houston, TXQorannoo 33
- Chicago, ILQorannoo 29
- Orlando, FLQorannoo 27
- Las Vegas, NVQorannoo 23
- Miami, FLQorannoo 23
- Dallas, TXQorannoo 20
- Atlanta, GAQorannoo 20
- New York City, NYQorannoo 19
- Jacksonville, FLQorannoo 19
- Washington, DCQorannoo 19
- Austin, TXQorannoo 18
Qorannoo biroo The Woodlands keessatti
- Kansara Qara'a Non-Small CellQorannoo 15
- ObesityQorannoo 12
- Saree OljooQorannoo 10
- Degenereshinii MakulaariiQorannoo 9
- Dhibee Onneessaa fi DhiigaQorannoo 9
- Kansara MetastatikiiQorannoo 9
- Sukkaraa Gosa 2Qorannoo 7
- Cufama OnneeQorannoo 7
- Dhibee QaraQorannoo 7
- AtherosclerosisQorannoo 6
- Atrophy GeographicaQorannoo 6
- Kansarii ProstateQorannoo 6
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.